Anemia, Hepcidin, and Vitamin D in Healthy Preterm Infants: A Pilot Study

Yael Koren1, Ronit Lubetzky2, Dror Mandel1

  • 1Department of Neonatology, Dana Dwek Children's Hospital, Tel Aviv Sourasky Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Insights

Anemia in premature infants is linked to higher hepcidin levels, a key regulator of iron metabolism. Further research is needed to understand the role of vitamin D in this condition.

Area of Science:

  • Neonatal Medicine
  • Pediatric Hematology
  • Endocrinology

Background:

  • Anemia in premature neonates is multifactorial, potentially involving inflammation-mediated hepcidin.
  • Hepcidin expression is known to be suppressed by vitamin D.

Purpose of the Study:

  • To investigate the interrelationship between hepcidin, anemia, and vitamin D status in preterm infants.
  • To compare hepcidin, ferritin, iron, 25-hydroxyvitamin D [25(OH)D], and C-reactive protein (CRP) levels between anemic and nonanemic preterm infants.

Main Methods:

  • Prospective recruitment of 47 preterm infants (1-5 weeks old) in a neonatal intensive care unit.
  • Measurement of blood counts and serum levels of hepcidin, ferritin, iron, 25(OH)D, and CRP.
  • Comparison of these parameters between anemic and nonanemic infants.

Main Results:

  • Anemic preterm infants had significantly higher hepcidin levels compared to nonanemic infants (55.3 vs. 30.1 ng/mL).
  • No significant differences in iron, ferritin, 25(OH)D, or CRP levels were observed between the groups.
  • A positive correlation was found between hepcidin and ferritin (R² = 0.247, p = 0.02).
  • A negative correlation was found between 25(OH)D and CRP (R² = 0.1, p = 0.04).

Conclusions:

  • Anemia of prematurity is associated with elevated serum hepcidin levels.
  • The precise mechanisms driving anemia in preterm infants and the specific role of vitamin D require further investigation.
Abstract